Cyclopropaneacetic acid → HCID 178520145, 화합물
반응식
Cl.[O:2]1[C:6]2[CH:7]=[CH:8][CH:9]=[C:10]([CH:11]3[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][C@H:19]4[CH2:24][CH2:23][C@H:22]([NH2:25])[CH2:21][CH2:20]4)[CH2:13][CH2:12]3)[C:5]=2[O:4][CH2:3]1.[CH:26]1([CH2:29][C:30](O)=[O:31])[CH2:28][CH2:27]1>>[O:2]1[C:6]2[CH:7]=[CH:8][CH:9]=[C:10]([CH:11]3[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][C@H:19]4[CH2:20][CH2:21][C@H:22]([NH:25][C:30](=[O:31])[CH2:29][CH:26]5[CH2:28][CH2:27]5)[CH2:23][CH2:24]4)[CH2:13][CH2:12]3)[C:5]=2[O:4][CH2:3]1참가 물질
3
실험 절차
The title compound, white solid (22.4 mg, 67.9%), MS (ISP) m/z=413.5 [(M+H)+], was prepared in accordance with the general method of example 1 from Trans-4-[2-(4-Benzo[1,3]dioxol-4-yl-piperidin-1-yl)-ethyl]-cyclohexylamine hydrochloride (intermediate A) (29.4 mg, 0.080 mmol) and 2-cyclopropylacetic acid.
출처 및 근거
- ORD 기록
- ord-e65d356b57d64c47a0fc1521438418f7
- 출처 데이터셋
- uspto-grants-2013_12
- 특허 번호
- US08598357B2
반응 노트
불러오는 중…